tiprankstipranks
Trending News
More News >
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
US Market

Adaptimmune Therapeutics (ADAP) Ratios

Compare
874 Followers

Adaptimmune Therapeutics Ratios

ADAP's free cash flow for Q4 2024 was $1.00. For the 2024 fiscal year, ADAP's free cash flow was decreased by $ and operating cash flow was $-21.98. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.92 2.85 3.96 6.64 10.19
Quick Ratio
2.80 2.85 3.94 6.63 10.14
Cash Ratio
1.41 1.98 1.67 2.40 1.46
Solvency Ratio
-0.25 -0.43 -0.65 -0.57 -1.11
Operating Cash Flow Ratio
-1.13 -1.94 -2.20 0.17 -1.37
Short-Term Operating Cash Flow Coverage
-15.55 0.00 -51.97 4.62 -19.33
Net Current Asset Value
$ -45.95M$ -35.55M$ 8.33M$ 151.87M$ 288.24M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.09 0.07 0.05 0.05
Debt-to-Equity Ratio
2.02 0.64 0.28 0.12 0.07
Debt-to-Capital Ratio
0.67 0.39 0.22 0.11 0.06
Long-Term Debt-to-Capital Ratio
0.62 0.00 0.20 0.10 0.06
Financial Leverage Ratio
20.76 7.15 4.02 2.28 1.32
Debt Service Coverage Ratio
-6.98 0.00 -57.95 -67.44 -45.43
Interest Coverage Ratio
-20.54 0.00 0.00 0.00 0.00
Debt to Market Cap
0.18 0.00 0.02 <0.01 <0.01
Interest Debt Per Share
0.02 0.02 0.02 0.03 0.03
Net Debt to EBITDA
1.28 0.93 0.55 0.80 0.26
Profitability Margins
Gross Profit Margin
99.96%83.65%-370.48%-1706.64%-2213.49%
EBIT Margin
-35.89%-228.99%-595.51%-2638.58%-3370.52%
EBITDA Margin
-29.58%-212.67%-573.13%-2531.78%-3178.65%
Operating Profit Margin
-38.62%-228.99%-603.97%-2638.58%-3370.52%
Pretax Profit Margin
-37.77%-186.68%-600.26%-2558.12%-3282.72%
Net Profit Margin
-39.78%-188.90%-609.46%-2570.99%-3286.81%
Continuous Operations Profit Margin
-39.78%-188.90%-609.46%-2570.99%-3286.81%
Net Income Per EBT
105.32%101.19%101.53%100.50%100.12%
EBT Per EBIT
97.79%81.52%99.39%96.95%97.40%
Return on Assets (ROA)
-28.79%-40.29%-50.30%-33.67%-28.84%
Return on Equity (ROE)
-597.64%-288.19%-202.08%-76.76%-38.12%
Return on Capital Employed (ROCE)
-37.90%-65.79%-62.01%-39.86%-32.37%
Return on Invested Capital (ROIC)
-38.90%-64.90%-61.69%-39.61%-31.98%
Return on Tangible Assets
-29.25%-40.34%-50.37%-33.74%-28.95%
Earnings Yield
-52.10%-71.41%-11.72%-4.51%-2.82%
Efficiency Ratios
Receivables Turnover
122.44 1.28 3.65 8.18 28.47
Payables Turnover
<0.01 1.21 26.87 13.69 14.33
Inventory Turnover
<0.01 0.00 99.86 148.91 43.90
Fixed Asset Turnover
3.48 0.84 0.38 0.12 0.08
Asset Turnover
0.72 0.21 0.08 0.01 <0.01
Working Capital Turnover Ratio
1.38 0.37 0.10 0.02 0.02
Cash Conversion Cycle
-7.15K -16.88 90.03 20.43 -4.33
Days of Sales Outstanding
2.98 284.09 99.96 44.64 12.82
Days of Inventory Outstanding
38.17K 0.00 3.65 2.45 8.32
Days of Payables Outstanding
45.32K 300.97 13.58 26.66 25.47
Operating Cycle
38.17K 284.09 103.62 47.09 21.13
Cash Flow Ratios
Operating Cash Flow Per Share
-0.05 -0.12 -0.15 0.01 -0.06
Free Cash Flow Per Share
-0.05 -0.12 -0.18 <0.01 -0.07
CapEx Per Share
0.00 <0.01 0.03 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.03 1.21 0.18 1.05
Dividend Paid and CapEx Coverage Ratio
0.00 -28.87 -4.77 1.22 -18.44
Capital Expenditure Coverage Ratio
0.00 -28.87 -4.77 1.22 -18.44
Operating Cash Flow Coverage Ratio
-3.05 -5.58 -6.14 0.42 -2.26
Operating Cash Flow to Sales Ratio
-0.41 -2.34 -5.22 1.74 -13.54
Free Cash Flow Yield
-8.98%-15.24%-12.15%0.06%-1.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.92 -1.40 -8.54 -22.17 -35.42
Price-to-Sales (P/S) Ratio
0.76 2.65 52.02 570.11 1.16K
Price-to-Book (P/B) Ratio
11.47 4.04 17.25 17.02 13.50
Price-to-Free Cash Flow (P/FCF) Ratio
-1.86 -1.09 -8.23 1.80K -81.55
Price-to-Operating Cash Flow Ratio
-1.86 -1.13 -9.96 326.74 -85.97
Price-to-Earnings Growth (PEG) Ratio
0.04 0.03 0.00 -1.66 1.11
Price-to-Fair Value
11.47 4.04 17.25 17.02 13.50
Enterprise Value Multiple
-1.31 -0.32 -8.53 -21.72 -36.36
EV to EBITDA
-14.21 -6.54 -8.53 -21.72 -36.36
EV to Sales
4.20 13.90 48.89 549.87 1.16K
EV to Free Cash Flow
-10.22 -5.75 -7.74 1.74K -80.96
EV to Operating Cash Flow
-10.22 -5.95 -9.36 315.14 -85.35
Tangible Book Value Per Share
<0.01 0.03 0.08 0.22 0.40
Shareholders’ Equity Per Share
<0.01 0.03 0.08 0.22 0.40
Tax and Other Ratios
Effective Tax Rate
-0.05 -0.01 -0.02 >-0.01 >-0.01
Revenue Per Share
0.12 0.05 0.03 <0.01 <0.01
Net Income Per Share
-0.05 -0.09 -0.17 -0.17 -0.15
Tax Burden
1.05 1.01 1.02 1.01 1.00
Interest Burden
1.05 0.82 1.01 0.97 0.97
Research & Development to Revenue
0.84 2.10 4.70 18.07 23.13
SG&A to Revenue
0.45 1.19 2.33 9.32 11.57
Stock-Based Compensation to Revenue
0.07 0.20 0.67 3.35 2.63
Income Quality
1.03 1.24 0.86 -0.07 0.41
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis